China is the largest emerging market in the world. It is also on the front lines of health diplomacy, where the tools of diplomatic statecraft are being employed by public health professions of both the US and China to help improve the practice of public health. This article examines the US Department of Health and Human Servicesâ€™ (HHS) and the US Centers for Control and Prevention (US CDC) in China, describes critical features of the Chinese health system, presents two examples of US-China collaborations, and describes common management mechanisms and strategies supporting both. This examination will help inform other global health collaborations between the US and China as well as lessons for supporting global health collaborations in other middle income countries.
Campbell D, Chui M. (2010) Pharmerging shake-up: New imperatives in a redefined world. imshealthcom. http://www.imshealth.com/deployedfiles/imshealth/Global/Content/StaticFile/Pharma_Shake-up_Imperatives_3_10.pdf, accessed 21 May 2012.
Yang, G., Kong, L., Zhao, W., Wan, X., Zhai, Y., Chen, LC. et al. (2008) Emergence of chronic non-communicable diseases in China. Lancet 372(9650):1697â€“705.
Gao, M. (1997) Continuing improvement in health quality of China's population. China Popul Today 14(1):17â€“8.
Gong, P., Liang, S., Carlton, EJ., Jiang, Q., Wu, J., Wang, L. et al. (2012) Urbanisation and health in China. Lancet 379(9818):843â€“52.
Pricewaterhousecoopers. (2009) Pharma 2020: Marketing the future - Which path will you take? Pharma 2020 series, http://www.pwc.com/gx/en/pharma-life-sciences/pharma-2020/pharma-2020-marketing-the-future-which-path-will-you-take.jhtml, accessed 21 May 2012.
Ma, J., Lu, M. and Quan, H. (2008) From A National, Centrally Planned Health System To A System Based On The Market: Lessons From China. Health Affairs 27(4):937â€“48.
Beach, M. (2001) China's rural health care gradually worsens. Lancet 358(9281):567â€“7.
Chinese Government. (2009) Ministry of Health. http://english.gov.cn/2005-10/09/content_75326.htm, accessed June 4, 2012.
Lu, X. and Gill, B. (2007) Chinaâ€™s Response to HIV/AIDS and U.S.- China Collaboration An Update from the CSIS Freeman Chair in China Studies. Center for Strategic and International Studies, http://csis.org/files/media/csis/pubs/071002-lu-gill-chinaresponsehiv4web.pdf, accessed June 4, 2012.
Lu, L., Jia, M., Ma, Y., Yang, L., Chen, Z., Ho, DD. et al. (2008) The changing face of HIV in China. Nature 455(7213):609â€“11.
Wu, Z., Wang, Y., Mao, Y., Sullivan, SG., Juniper, N. and Bulterys, M. (2011) The integration of multiple HIV/AIDS projects into a coordinated national programme in China. Bull. World Health Organ 89(3):227â€“33.
Chan, L-H., Chen, L. and Xu, J. (2010) China's Engagement with Global Health Diplomacy: Was SARS a Watershed? PLoS Med 7(4):e1000266.
Feng, Z., Li, W. and Varma, JK. (2011) Gaps Remain In China's Ability To Detect Emerging Infectious Diseases Despite Advances Since The Onset Of SARS And Avian Flu. Health Affairs 30(1):127â€“35.
Unless specified by prior arrangement, the author agrees to the following terms and assurances:
- For myself and on behalf of the other authors listed on this work, I assign to thinkBiotech LLC the copyright* in the contribution for the full term throughout the world.
- I/we further give to the following assurances
- I am the sole author of the contribution, or, if not, I have the written authority of the other authors to transfer the copyright* to thinkBiotech LLC and give these warranties;
- I and (where appropriate) the other authors are entitled to transfer the copyright to thinkBiotech LLC and no one else would be entitled to prevent us from publishing the contribution;
- To the best of my/our knowledge, all the facts in the contribution are true and accurate;
- The content of the contribution is entirely original to me (and where appropriate to the other authors) or, if not, the written permission of the owner of the copyright in any material copied from elsewhere has been obtained for all media (all such permissions to be attached to the contribution as supplementary files);
- Nothing in the contribution is obscene or libellous;
- Nothing in the contribution infringes any duty of confidentiality which I/or the other authors may owe to anyone else.
- I and/or the other authors have obtained the appropriate clearances from my/our employer(s) or other concerned institution(s).